US$ 29.41
exercise timing glp-1 medications effectiveness 2025 Frontiers A network meta-analysis backed weight-loss
Description
Approved by our Chief Medical Board, third-party tested for purity and efficacy
The researchers analyzed data from a large, multi-institutional medical records database, including 73,483 adults taking GLP-1sincluding Semaglutide drugs like Ozempic & Wegovy, as well as Victoza (Liraglutide), Trulicity (Dulaglutide), or Byetta (Exenatide)and compared them with the same number of adults not taking the medications, tracking health outcomes for five years after treatment began

Peak GLP-1 increases were significantly higher (~32%) after RYGB at both follow-ups (p<0.05)

While prescription versions can amplify its effects, physicians say diet, movement and metabolic health still shape how well GLP-1 works naturally.

GLP-1s are not just another diabetes medication
